Medical Devices

Galectin Therapeutics adds legendary neurosurgeon Dr. Henry Brem to its board, a strategic move to leverage his drug development expertise for its lead liver drug.

Exiting stealth, PerturbAI releases an 8-million-cell map of gene function in a living brain, aiming to slash the cost and time of creating new drugs.

BioCardia's FDA milestone for its Helix catheter could unlock a new era of targeted heart therapies, but financial hurdles and clinical questions remain.

A new telehealth model challenges the prescription-first approach, combining GLP-1s with 24/7 clinical support. Is this the future of metabolic health?

Princess Padmaja Kumari Parmar receives the Mary Tyler Moore Award for her advocacy, bridging a legacy of hope with a modern fight for global T1D equity.

A new exoskeleton, validated by scientific studies, shows a dramatic reduction in muscle strain and discomfort for surgeons, dentists, and industrial workers.

Regulatory pressure ends a major ophthalmic deal, forcing LENSAR to forge ahead alone with its ALLY system and a $10M deposit. What's next?

Facing a challenging EV market, Aspen Aerogels looks to the Roth Conference to showcase its long-term growth strategy and advanced aerogel technology.

Riding a wave of record revenue and a new product launch, iRadimed showcases its MRI-compatible device dominance to investors, aiming to fuel future growth.

As essential pediatric care costs skyrocket, families of children with cerebral palsy face a silent crisis of debt, stress, and impossible choices.

The global manufacturer's latest acquisition adds key blow molding capabilities and expands its U.S. footprint, signaling a major push into the medical sector.

Facing critical staff shortages, Rochester Regional Health offers up to $180,000 in loan relief to secure vital healthcare roles for the community.

A new study at GBMC tests an AI-powered artificial larynx, offering hope to millions of voiceless ICU patients and aiming to transform critical care.

With a new CEO known for successful exits and a breakthrough PFA system for complex arrhythmias, Field Medical is poised to disrupt the cardiac ablation market.

The spinal device firm will meet investors at the key small-cap conference, balancing a story of innovation against mixed financial results.

With its lead autoimmune drug nearing FDA review and a new $250M in funding, Zenas BioPharma prepares for a major leap from R&D to market.

Nasus Pharma's NS002 nasal spray reached critical therapeutic levels in half the time of EpiPen, heralding a potential new era for anaphylaxis treatment.

As MediciNova execs meet investors at the ROTH Conference, all eyes are on pivotal updates for its ALS, MS, and NAFLD drug candidates.

Despite a revenue dip, Kelyniam Global slashed its net loss, secured FDA clearance for a breakthrough implant, and rejected a buyout, charting its own course.

Riyadh's KFSH performed 130 paired kidney transplants in 2025, the most by any single center worldwide, revolutionizing access to organ donation.